+

WO2007046125A3 - Use of extracts of myrtle and other mediterranean plant species, as antimycotic agent towards yeast and yeast-like microorganisms - Google Patents

Use of extracts of myrtle and other mediterranean plant species, as antimycotic agent towards yeast and yeast-like microorganisms Download PDF

Info

Publication number
WO2007046125A3
WO2007046125A3 PCT/IT2006/000743 IT2006000743W WO2007046125A3 WO 2007046125 A3 WO2007046125 A3 WO 2007046125A3 IT 2006000743 W IT2006000743 W IT 2006000743W WO 2007046125 A3 WO2007046125 A3 WO 2007046125A3
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
extracts
myrtle
microorganisms
plant species
Prior art date
Application number
PCT/IT2006/000743
Other languages
French (fr)
Other versions
WO2007046125A2 (en
Inventor
Annalisa Romani
Pietro Buzzini
Innocenza Chessa
Flavia Franconi
Patrizia Pinelli
Benedetta Turchetti
Giovanni Nieddu
Original Assignee
Annalisa Romani
Pietro Buzzini
Innocenza Chessa
Flavia Franconi
Patrizia Pinelli
Benedetta Turchetti
Giovanni Nieddu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Annalisa Romani, Pietro Buzzini, Innocenza Chessa, Flavia Franconi, Patrizia Pinelli, Benedetta Turchetti, Giovanni Nieddu filed Critical Annalisa Romani
Priority to EP06810032A priority Critical patent/EP1945237A2/en
Publication of WO2007046125A2 publication Critical patent/WO2007046125A2/en
Publication of WO2007046125A3 publication Critical patent/WO2007046125A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention is directed to the preparation of natural extracts of myrtle, cistus, arbutus, lentisk and other Mediterranean plant species extracts (standardized in the content of polyphenolic molecules), isolated both from different plant tissues and by-products deriving from artisan or industrial manufactures carried out on the same species. The utilization of the above extracts as antimycotic agents is related to its activity towards yeast and yeast-like microorganisms of biomedical interest.
PCT/IT2006/000743 2005-10-20 2006-10-17 Use of extracts of myrtle and other mediterranean plant species, as antimycotic agent towards yeast and yeast-like microorganisms WO2007046125A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06810032A EP1945237A2 (en) 2005-10-20 2006-10-17 Use of extracts of myrtle and other mediterranean plant species, as antimycotic agent towards yeast and yeast-like microorganisms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI2005A000219 2005-10-20
IT000219A ITFI20050219A1 (en) 2005-10-20 2005-10-20 USE OF MIRTO EXTRACTS AND OTHER MEDITERRANEAN STAIN PLANTS STANDARDIZED IN POLYPHENOLIC CONTENT AS AN AGENT WITH ANTIMICOTIC ACTIVITY TOWARDS YEAST-SIMILAR YEAST AND MICROORGANISMS

Publications (2)

Publication Number Publication Date
WO2007046125A2 WO2007046125A2 (en) 2007-04-26
WO2007046125A3 true WO2007046125A3 (en) 2007-09-20

Family

ID=37807760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2006/000743 WO2007046125A2 (en) 2005-10-20 2006-10-17 Use of extracts of myrtle and other mediterranean plant species, as antimycotic agent towards yeast and yeast-like microorganisms

Country Status (3)

Country Link
EP (1) EP1945237A2 (en)
IT (1) ITFI20050219A1 (en)
WO (1) WO2007046125A2 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541949A1 (en) * 1985-11-27 1987-06-04 Chemolux Gmbh Process for utilising citrus fruit wastes
WO1997018823A1 (en) * 1995-11-17 1997-05-29 Pierre Fabre Dermo-Cosmetique Combination of a myrtle extract and antifungal agents
GR1003541B (en) * 1999-05-11 2001-03-07 Chios mastic oil used for cosmetic & pharmaceutical purposes as well as for the production of toothpicks, chewing gums, and dental flosses
WO2001015680A1 (en) * 1999-09-01 2001-03-08 Van Beek Global/Ninkov L.L.C. Composition for treatment of infections of humans and animals
WO2001045650A2 (en) * 1999-12-22 2001-06-28 Cognis France, S.A. Cosmetic use of the residues from wine production
GR1003832B (en) * 2001-04-30 2002-03-04 Γεωργιος Σοδης Use of mastic oil and natural mastic for medicinal and cosmetic preparations
WO2003080006A1 (en) * 2002-03-22 2003-10-02 Gognis Deutschland Gmbh & Co. Kg Use of extracts from olive trees as anti-dandruff agents
EP1352905A1 (en) * 2000-12-22 2003-10-15 Consejo Superior De Investigaciones Cientificas Flavanol and cysteamine conjugates
WO2004048498A1 (en) * 2002-11-25 2004-06-10 Nichirei Biosciences Inc. Antioxidant, skin preparation for external use, cosmetic and food

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541949A1 (en) * 1985-11-27 1987-06-04 Chemolux Gmbh Process for utilising citrus fruit wastes
WO1997018823A1 (en) * 1995-11-17 1997-05-29 Pierre Fabre Dermo-Cosmetique Combination of a myrtle extract and antifungal agents
GR1003541B (en) * 1999-05-11 2001-03-07 Chios mastic oil used for cosmetic & pharmaceutical purposes as well as for the production of toothpicks, chewing gums, and dental flosses
WO2001015680A1 (en) * 1999-09-01 2001-03-08 Van Beek Global/Ninkov L.L.C. Composition for treatment of infections of humans and animals
WO2001045650A2 (en) * 1999-12-22 2001-06-28 Cognis France, S.A. Cosmetic use of the residues from wine production
EP1352905A1 (en) * 2000-12-22 2003-10-15 Consejo Superior De Investigaciones Cientificas Flavanol and cysteamine conjugates
GR1003832B (en) * 2001-04-30 2002-03-04 Γεωργιος Σοδης Use of mastic oil and natural mastic for medicinal and cosmetic preparations
WO2003080006A1 (en) * 2002-03-22 2003-10-02 Gognis Deutschland Gmbh & Co. Kg Use of extracts from olive trees as anti-dandruff agents
WO2004048498A1 (en) * 2002-11-25 2004-06-10 Nichirei Biosciences Inc. Antioxidant, skin preparation for external use, cosmetic and food
EP1602704A1 (en) * 2002-11-25 2005-12-07 Nichirei Corporation Antioxidant, skin preparation for external use, cosmetic and food

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; E. DOMINGUEZ ET AL: "Effect of seed extract of Myrtus Communis on teh growth of Candida Utilis and Saccharomyces Cerevisiae", XP002424588 *
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; S. C. GARG ET AL: "Antifungal activity of the essential oil of Myrtus-Communis-Var-Microphylla", XP002424587 *
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; A. ROMANI ET AL: "Evaluation of Antioxidant effect of different extracts of Myrtus communis L.", XP002424590 *
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; G. A. EL HOSSARY ET AL: "Phytochemical study of the leaves of Myrtus communis L. grown in Egypt", XP002424589 *

Also Published As

Publication number Publication date
ITFI20050219A1 (en) 2007-04-21
EP1945237A2 (en) 2008-07-23
WO2007046125A2 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2007141392A3 (en) Compositions comprising betulonic acid
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
WO2007064954A3 (en) Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
WO2008013899A3 (en) Rhamnolipid-based formulations
WO2005077093A3 (en) Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
WO2008009379A3 (en) Active ingredient combinations having insecticide and acaricide properties
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006136420A3 (en) Methods and means for protecting the skin against pathogenic microorganisms
WO2009077471A3 (en) Azolylmethyloxiranes, use thereof and agents containing the same
MX2012006628A (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion.
WO2007028012A3 (en) Antibacterial 6'-n-modified 4,5-substituted aminoglycoside analogs
WO2010046291A3 (en) Use of hydroxycinnamic acids and derivatives thereof and/or of plant extracts for treating body odor
WO2007067416A3 (en) Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
WO2009085889A3 (en) Compositions and methods for reducing or preventing water loss from the skin
WO2008054698A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2006078576A3 (en) Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
WO2008036379A3 (en) Serine hydrolase inhibitors
WO2007038627A3 (en) Stabilized antimicrobial compositions and related methods of preparation
WO2008031940A3 (en) Xanthoxyline-based composition and cosmetic use thereof
WO2009101321A3 (en) Cationic surfactant compounds, use thereof as conditioner, cosmetic treatment method, and cosmetic or pharmaceutical compositions comprising same
MX2007011381A (en) Spirulin composition rich in active principles, method for obtaining same and use thereof.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006810032

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2006810032

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载